okedi
laboratorios farmacéuticos rovi, s.a. - risperidone - skizofreni - psykoleptika - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
cleosensa 3 mg+0,02 mg filmovertrukne tabletter
actavis group ptc ehf. - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3 mg+0,02 mg
cleosensa 3 mg+0,03 mg filmovertrukne tabletter
actavis group ptc ehf. - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3 mg+0,03 mg
cleosensa 28 3 mg+0,02 mg filmovertrukne tabletter
actavis group ptc ehf. - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3 mg+0,02 mg
centium 36 cs kapselsuspension
fmc europe nv, agrochemical products group - clomazon - kapselsuspension - 360 g/l clomazon
attane vet. 1000 mg/g væske til inhalationsdamp
piramal critical care b.v. - isofluran - væske til inhalationsdamp - 1000 mg/g - fjerkræ, hest, hund, kat, pelsdyr (f.eks. mink), reptiler, små gnavere (f.eks. kaniner)
vetflurane 1000 mg/g væske til inhalationsdamp
virbac s.a. - isofluran - væske til inhalationsdamp - 1000 mg/g - fjerkræ, hest, hund, kat, pelsdyr (f.eks. mink), reptiler, små gnavere (f.eks. kaniner)
isothesia 1000 mg/g væske til inhalationsdamp
piramal critical care b.v. - isofluran - væske til inhalationsdamp - 1000 mg/g
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
isoflutek 1000 mg/g væske til inhalationsdamp
laboratorios karizoo, s.a. - isofluran - væske til inhalationsdamp - 1000 mg/g